1

A Look at Qui Tam Actions in Pharmaceutical Litigation

News Discuss 
Whistleblower settlements have become increasingly common in the medical device industry, particularly when cases involve allegations related to Medicare billing and promotion practices. The regulatory environment governing these cases centers on the False Claims Act, which allows private whistleblowers to file qui tam cases on behalf of the government. Qui https://joseona826amy4.azzablog.com/profile

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story